Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

FDA’s Shuren: Staff Overburdened, Review Times Seeing Negative Effects

Feb 18 2021

Shuren_Jeff_1200 — CDRH director Jeff Shuren is worried his staff are burning out and as a result reviews are taking longer • Source: Ferdous Al-Faruque

Related Content

Shuren Gives Peek Behind Curtain With 3 Lessons FDA’s Device Center Learned During Pandemic

Sep 21 2020

Hahn Praises CDRH Staff For Mitigating COVID-19 Deaths

Sep 29 2020

Shuren: CDRH Writing Guidance To Explain What Should Happen To All Those EUA Tests, Devices

Sep 22 2020

Podcast: Exclusive – Top Medical Device Lobbyist On User-Fee Talks, Biden And New Congress, Implementing MCIT Rule

Feb 01 2021

COVID-19-Related EUAs Bolster Record Number Of Novel Devices Greenlit By FDA

Feb 16 2021

Top CDRH Officials Tell EUA Holders: Don’t Procrastinate In Getting Products FDA-Approved

Oct 08 2020

Additional Topics

United States Regulation Policy Coronavirus COVID-19 Enforcement FDA Guidance Documents Innovation Leadership Legislation Manufacturing Review Pathway Risk Management User Fees Infectious Diseases Medical Device

More from Regulation

More from Policy & Regulation

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window